Drugs & Targets City of Hope and Sorrento Therapeutics form LA Cell Inc. October 02, 2015Vol.41 No.36
Drugs & Targets FDA Approves Varubi for Chemotherapy-Induced Nausea and Vomiting October 01, 2015Vol.38 No.09
Telotristat Etiprate Demonstrates Clinical Benefit in Phase III Carcinoid Syndrome Study October 01, 2015Vol.38 No.09
Cyramza Increases PFS In Phase II Study of Bladder Cancer Patients Who Failed Platinum Therapy October 01, 2015Vol.38 No.09
